The latest news & events

Keep up to date with company updates, industry news, investor
press releases and event information.

Investor News - General : 27 Feb 2020

Kneat Announces $11 Million Overnight Marketed Equity Financing

Not for distribution to United States newswire services or for dissemination in the United States HALIFAX , Feb. 27, 2020 /CNW/  – kneat.com, inc. (TSXV: KSI) (“Kneat”) is pleased to announce that, in connection with its previously announced overnight marketed offering, it has entered into an

Read More
Investor News - General : 6 Feb 2020

Global Medical Device Leader Selects Kneat’s SaaS Platform

LIMERICK, Ireland, February 6, 2020/CNW/  – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a three-year software as a service (“SaaS”) agreement with a top tier medical device company. This global company with operations in over 70 countries and over 20,000

Read More
News : 22 Jan 2020

January 22, 2020 | Kneat Expands Into Additional Green Workspace in Limerick

LIMERICK, Ireland January 22, 2020 – Kneat has signed a new lease agreement to occupy 12,700 sq. ft. at Hawthorn…

Read More
News : 6 Jan 2020

January 06, 2020 | Kneat Launches Training Arm “Kneat Academy”

LIMERICK, Ireland January 06, 2020 – Kneat is pleased to announce the launch of its newly established training arm, Kneat…

Read More
Events : 10 Mar 2020

Kneat joins 2020 ISPE CASA Life Sciences Technology Conference

2020 ISPE CASA Life Sciences Technology Conference, March 10, Durham, USA The 2020 ISPE CASA Life Sciences Technology Conference, March…

Read More
Events : 30 Jan 2020

Kneat to exhibit at 2020 ISPE Facilities of the Future

Facilities of the Future 2020, Jan. 30-31, San Francisco, USA The 2020 ISPE Facilities of the Future, January 30 –…

Read More
Investor News - General : 11 Dec 2019

Kneat Signs Global Biopharma Leader

LIMERICK, Ireland December 11, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another of the world’s leading biopharmaceutical companies. This US headquartered company has over 10,000 employees and operations

Read More
Investor News - General : 26 Nov 2019

Kneat Reports Third Quarter Results

LIMERICK, Ireland, November 26, 2019 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) today announced its financial results for the quarter ended September 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated.   Third Quarter Highlights Revenue of $1,586,033 was

Read More
Investor News - General : 25 Nov 2019

Big Pharma selects Kneat’s SaaS Platform for Digitalization of its Validation Work Processes

LIMERICK, Ireland November 25, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another one of the worlds largest pharmaceutical companies, to digitalize key validation processes across its manufacturing sites.

Read More
Events : 19 Nov 2019

Kneat Sponsors ISPE Greater Los Angeles Chapter Conference

Data Integrity ISPE LA 2019, December 05, Los Angeles, USA Data Integrity ISPE LA 2019, takes place on December 5th…

Read More
Events : 19 Nov 2019

Kneat to exhibit at ManuPharma 2019

ManuPharma 2019, December 03-04, Frankfurt ManuPharma 2019, takes place on December 3rd – 4th in Frankfurt, Germany ManuPharma is firmly…

Read More
Investor News - General : 20 Sep 2019

Kneat Appoints New Chief Financial Officer

LIMERICK, Ireland September 20, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat or the company”) today announced that it has appointed Mr. Hugh Kavanagh as its Chief Financial Officer effective September 23, 2019 following the resignation of Ms. Sarah Oliver who will assist in the transition. Mr.

Read More

Sign Up to Our Newsletter

Contact

Talk to us

Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.

Europe: +353-61-203826
U.S: +1 888 88 KNEAT
Canada: +1 902 706 9074